MYOPIA CLINIC MELBOURNE
Repeated Low-Level Red Light Therapy
RLRL
Repeated low level red light therapy is a promising approach for myopia management. This treatment involves the use of red light to stimulate the retina and slow down the progression of myopia.
With increasing research evidence demonstrating effectiveness in slowing the axial elongation of the eye in myopia, repeated low level red light therapy is gaining attention as a new alternative option for myopia management.
What is RLRL?
A NEW TREATMENT FOR MYOPIA
Red light therapy for myopia is a new and innovative treatment that aims to slow down the progression of nearsightedness in children. It involves exposing the eyes to a low-level red light for a few minutes every day, using a special device that is worn like a pair of glasses. The red light may stimulate the cells in the retina, the back of the eye, and improve the focus of light on it. This may prevent the eye from growing too long, which is the main cause of myopia.
Red light therapy for myopia is based on the idea that natural bright light can protect against myopia by influencing the eye growth and development. However, since many children spend more time indoors and use digital devices, they may not get enough exposure to natural light. Red light therapy may offer a convenient and effective alternative that can be done at home, under parental supervision.
Red light therapy for myopia has been tested in clinical trials and has shown promising results. It has been found to be safe, easy to use, and well-accepted by children. It has also been shown to reduce the axial length and refractive error of the eye, which are the main indicators of myopia progression. However, more research is needed to confirm the long-term benefits, safety profile, and optimal dosage of red light therapy for myopia.
Eyerising Myoproclear
NOW AVAILABLE AT MYOPIA CLINIC MELBOURNE
The Eyerising Myoproclear device is a new and innovative device that uses repeated low-level red-light (RLRL) therapy to slow down the progression of myopia in children aged 3-16 years old. It is a home-use device that is worn like a pair of glasses and delivers red light to the eyes for 3 minutes, twice a day, 5 days per week. The red light may enhance blood circulation in the retina and prevent the eye from growing too long, which is the main cause of myopia.
The Eyerising Myoproclear device has been clinically tested and proven to be safe and effective in reducing the axial length and refractive error of the eye, which are the main indicators of myopia progression. It may also reduce the risk of developing high myopia and its complications later in life. The device is easy to use and has a touchscreen interface that allows the user to monitor their treatment and compliance. The device also securely shares the data with the eye doctor, who can provide guidance and feedback.
The Eyerising Myoproclear device is a promising option for myopia management that does not require drugs, injections, contact lenses, or surgery. It may offer a convenient and affordable alternative to other treatments, or complement them for better results.
If you are interested in red light therapy for your child, book an appointment with us to assess your child's suitability for this treatment and for an in-person demonstration of the device.